The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Sodium Oxybate
Sodium Oxybate · SODIUM OXYBATE 500 mg/mL · Solution · Oral · Amneal Pharmaceuticals LLC
NDC 65162-0065-87 · 1 BOTTLE in 1 CARTON / 180 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Amneal Pharmaceuticals LLCUnited Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $15,752.09 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Sodium Oxybate Shared System REMS
Regulatory
- Application
- ANDA203631
- TE code
- AA
- Approval date
- Sep 10, 2025
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Sodium Oxybate (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | SODIUM OXYBATE 500 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | SODIUM OXYBATE .5 g/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | SODIUM OXYBATE .5 g/mL | Jul 15, 2026 | Sep 2, 2026 |
| Jazz Pharmaceuticals, Inc. | SODIUM OXYBATE .5 g/mL | Jul 15, 2026 | Sep 2, 2026 |
| XLCare Pharmaceuticals, Inc. | SODIUM OXYBATE .5 g/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Sodium Oxybate — NDC 65162-0065-87," retrieved September 3, 2026, https://drugdashboards.com/drug/65162006587.
Free to cite with attribution — see how the data is put together.